| AEA | Anandamide, N-Arachidonoylethanolamine, N-Arachidonylethanolamide |
| 2-AG | 2-Arachidonoylglycerol |
| AraS | N-Arachidonoyl-L-serine |
| CBC | Cannabichromene |
| CBCA | Cannabichromenic acid |
| CBD | Cannabidiol |
| CBDA | Cannabidiolic acid |
| CBG | Cannabigerol |
| CBN | Cannabinol |
| CFU | Colony-forming unit |
| C. sativa L. | Cannabis sativa Linnaeus |
| DAGL | Diacylglycerol lipase |
| ECS | Endocannabinoid system |
| EPS | Extracellular polymeric substances |
| FAAH | Fatty acid amide hydrolase |
| GPCR | G-protein-coupled receptor |
| GPR18/GPR55 | G-protein-coupled receptors 18/55 |
| IBD | Inflammatory bowel disease |
| IC50 | Half maximal inhibitory concentration |
| LD50 | Half maximal lethal dose |
| LEA | N-Linoleoylethanolamine |
| MBEC | Minimum biofilm eradication concentration |
| MBIC | Minimum biofilm inhibitory concentration |
| MIC | Minimum inhibitory concentration |
| MDRSA | Multidrug resistant Staphylococcus aureus |
| MSSA | Methicillin sensitive Staphylococcus aureus |
| MRSA | Methicillin resistant Staphylococcus aureus |
| NAE | N-Acylethanolamine |
| NAPE | N-Acyl-phosphatidylethanolamine |
| OEA | Oleoylethanolamine |
| OLDA | N-Oleoyldopamine |
| PALDA | N-Palmitoyldopamine |
| PEA | Palmitoylethanolamine |
| PIP2 | Phosphatidylinositol-4,5-bisphosphate |
| PPARα/γ | Peroxisome proliferator activated receptor α/γ |
| Psmα | α-Helical phenol-soluble modulin |
| SCFA | Small chain fatty acid |
| STEARDA | N-Stearoyldopamine |
| Δ9-THC | Δ9-Tetrahydrocannabinol |
| THCA | Tetrahydrocannabinolic acid |
| TRPA1 | Ankyrin-type 1 transient receptor potential channel |
| TRPM8 | Transient receptor potential cation channel subfamily M (melastatin) member 8 |
| TRPV1 | Transient receptor potential vanilloid-1 |